Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer

Based on the results of combined data from three North American Phase II studies, a randomised Phase II study in the same patient population was performed, using combination chemotherapy with estramustine phosphate (EMP) and vinblastine (VBL) in hormone refractory prostate cancer patients. In all, 9...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Albrecht, W, Van Poppel, H, Horenblas, S, Mickisch, G, Horwich, A, Serretta, V, Casetta, G, Maréchal, J M, Jones, W G, Kalman, S, Sylvester, R
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2004
Teme:
Clinical
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395315/
https://ncbi.nlm.nih.gov/pubmed/14710214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601468
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items